Compare IRWD & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | DDI |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.8M | 607.0M |
| IPO Year | 2009 | 2020 |
| Metric | IRWD | DDI |
|---|---|---|
| Price | $4.10 | $12.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $7.67 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 1.6M | 112.1K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1400.00 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $298,276,000.00 | N/A |
| Revenue This Year | $57.95 | $6.65 |
| Revenue Next Year | $4.39 | $2.64 |
| P/E Ratio | $7.40 | ★ $4.31 |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $1.23 | $8.10 |
| 52 Week High | $5.78 | $13.28 |
| Indicator | IRWD | DDI |
|---|---|---|
| Relative Strength Index (RSI) | 43.29 | 59.45 |
| Support Level | $3.89 | $12.60 |
| Resistance Level | $4.53 | $13.28 |
| Average True Range (ATR) | 0.17 | 0.29 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 8.33 | 36.77 |
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States, while it also has its presence in Canada, Germany, United Kingdom, and International-Other. The games offered by the company are: Doubledown Casion, Doubledown Fortknox, and Doubledown Classic Slots.